Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Test procedure  





2 Specimen requirements  





3 Reference ranges  





4 Limitations  





5 See also  





6 References  





7 External links  














Thrombin time






العربية
Čeština
Deutsch
Français
Italiano
Polski
Português
Русский
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Thrombin time
Blood coagulation pathways in vivo showing the central role played by thrombin
Other namesTCT
MeSHD013918

[edit on Wikidata]

The thrombin time (TT), also known as the thrombin clotting time (TCT), is a blood test that measures the time it takes for a clot to form in the plasma of a blood sample containing anticoagulant, after an excess of thrombin has been added.[1] It is used to diagnose blood coagulation disorders and to assess the effectiveness of fibrinolytic therapy. This test is repeated with pooled plasma from normal patients. The difference in time between the test and the 'normal' indicates an abnormality in the conversion of fibrinogen (a soluble protein) to fibrin, an insoluble protein.[2]

The thrombin time compares the rate of clot formation to that of a sample of normal pooled plasma. Thrombin is added to the samples of plasma. If the time it takes for the plasma to clot is prolonged, a quantitative (fibrinogen deficiency) or qualitative (dysfunctional fibrinogen) defect is present.[3] In blood samples containing heparin, a substance derived from snake venom called batroxobin[4] (formerly reptilase) is used instead of thrombin. Batroxobin has a similar action to thrombin but unlike thrombin it is not inhibited by heparin.[1]

Normal values for thrombin time are 12 to 14 seconds.[5] If batroxobin is used, the time should be between 15 and 20 seconds. Thrombin time can be prolonged by heparin, fibrin degradation products, and fibrinogen deficiency or abnormality.

Test procedure[edit]

After separating the plasma from the whole blood by centrifugation, bovine thrombin is added to the sample of plasma. Clot formation is detected optically or mechanically by a coagulation instrument. The time between the addition of the thrombin and the clot formation is recorded as the thrombin clotting time.[citation needed]

Specimen requirements[edit]

Whole blood is taken with either citrateoroxalate additive (if using the vacutainer system, this is a light blue top tube). As with other coagulation assays, the tube must not be over- or under-filled in order to ensure the correct anticoagulant-to-blood ratio: one part anticoagulant per nine parts blood.[citation needed]

Reference ranges[edit]

The reference ranges of the thrombin clotting time is generally <22 seconds,[6] and from 14 to 16 seconds.[5] Laboratories usually calculate their own ranges, based on the method used and the results obtained from healthy individuals from the local population. Separate ranges are used for infants.[7]

Limitations[edit]

Blood samples that are more than eight hours old can give inaccurate results when tested.[8]

See also[edit]

References[edit]

  1. ^ a b David Lillicrap; Nigel Key; Michael Makris; Denise O'Shaughnessy (2009). Practical Hemostasis and Thrombosis. Wiley-Blackwell. p. 53. ISBN 978-1-4051-8460-1.
  • ^ Popović M, Smiljanić K, Dobutović B, Syrovets T, Simmet T, Isenović ER (January 2012). "Thrombin and vascular inflammation". Molecular and Cellular Biochemistry. 359 (1–2): 301–13. doi:10.1007/s11010-011-1024-x. PMID 21858738. S2CID 14313728.
  • ^ Hatton, Chris (2008). Haematology (Lecture Notes). Cambridge, MA: Blackwell Publishers. p. 156. ISBN 978-1-4051-8050-4.
  • ^ Batroxobin factsheet
  • ^ a b Hoffbrand, A. V. (2002). Essential haematology. Oxford: Blackwell Science. p. 248. ISBN 978-0-632-05153-3.
  • ^ Gastineau DA, Gertz MA, Daniels TM, Kyle RA, Bowie EJ (June 1991). "Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality". Blood. 77 (12): 2637–40. doi:10.1182/blood.V77.12.2637.2637. PMID 1904284.
  • ^ "Screening Tests in Haemostasis: The Prothrombin Time [PT]". practical-haemostasis.com.
  • ^ Heil W, Grunewald R, Amend M, Heins M (June 1998). "Influence of time and temperature on coagulation analytes in stored plasma". Clinical Chemistry and Laboratory Medicine. 36 (7): 459–62. doi:10.1515/CCLM.1998.077. PMID 9746270. S2CID 23594097.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Thrombin_time&oldid=1084142284"

    Category: 
    Blood tests
    Hidden categories: 
    All articles with unsourced statements
    Articles with unsourced statements from July 2020
     



    This page was last edited on 22 April 2022, at 19:37 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki